Research on the effectiveness of stem cells in the treatment of liver diseases using regenerative medicine and its control with AI

Article Sidebar

21-Oct-5813.pdf
Published Oct 29, 2024
DOI: https://doi.org/10.18103/mra.v12i10.5813

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Chien-Hua Liao
Academic consultant and professor of the Artificial Intelligence International Health Management Society & Consultant and chairman of the studio of Professor Hong Ruliao, Yunlin, Taiwan
Hou Ming
Researcher, Shanghai Nanbinjiang Stem Cell Research Centre1 & Ph.D., Institute of Advanced Business Administration, Shanghai Campus, emlyon business school, France
Jiang Yuan
Professor at the Institute of Advanced Business Administration, Emlyon Business School, Shanghai Campus, France
Wen-Feng Huang
Postdoctoral Fellow and Visiting Scholar at Hamerton College, University of Cambridge, UK & Vice-Chancellor of the University of the Pacific R.O.C

Abstract

Research on using regenerative medicine stem cells to treat liver disease and other anti-aging, anti-cancer and prolong life has always been a hot topic in social research on aging chronic diseases. Liver disease is indeed difficult to cure. Once discovered, there is no way to cure it in a short time. The treatment and anti-aging effect of stem cells for liver diseases depend on the detoxification ability of stem cells and their ability to scavenge free radicals. I attach great importance to laboratory preservation management and clinical application, and use AI to control the laboratory to quickly enter new medical fields. The effect of stem cell culture on the activation of dead cells is also used to deal with it. When stem cells are injected into tissue that is damaged or in need of repair, they can be reinfused intravenously to replace functional cells in the damaged tissue. In clinical applications, artificial intelligence AI is used to control various treatment results and achieve excellent control effects. This is the result of this stem cell research center. Stem cell therapy seeks new opportunities by borrowing allogeneic cell raw materials. It can also overcome the problem of autologous cell transplantation. Therefore, this study allows liver disease patients to save a life through stem cell therapy! It is indeed a major breakthrough in medicine that deserves to be cheered and continued to be studied in depth. importance.

Keywords: A Comparative Study, Liver disease, Anti-Aging Effects, Allogeneic, Autologous, Mesenchymal Stem Cell Therapy, Anti-tumor

Article Details

How to Cite
LIAO, Chien-Hua et al. Research on the effectiveness of stem cells in the treatment of liver diseases using regenerative medicine and its control with AI. Medical Research Archives, [S.l.], v. 12, n. 10, oct. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5813>. Date accessed: 15 nov. 2024. doi: https://doi.org/10.18103/mra.v12i10.5813.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 12 No 10 (2024): October Issue, Issue 10, VOl.12
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Shih-Yin Chen, Meng-chieh Lin, Jia-Shiuan Tsai, Pei-Lin He, Wen-Ting Luo, Ing-Ming Chiu, Harvey R. Herschman, Hua-Jung Li. Exosomal 2’,3’-CNP from mesenchymal stem cells promotes hippocampus CA1 neurogenesis /neuritogenesis and contributes to rescue of cognition/ learning deficiencies of damaged brain. STEM CELLS Transl Med. 2020; 9:499–517.
2. Ancans, J. Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development. Front. Immunol. 3, 253 (2012).
3. Ming‐Song Tsai, Jia‐Ling Lee, Yu‐Jen Chang, Shiaw‐Min Hwang. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two stage culture protocol. Human Reproduction 2004; 19:1450–1456.
4. Rhian Stavely, Kulmira Nurgali. The emerging antioxidant paradigm of mesenchymal stem cell therapy. STEM CELLS Transl Med. 2020;9:985–1006.
5. Shih-Yin Chen, Meng-Chieh Lin, Jia-Shiuan Tsai, Pei-Lin He, Wen-Ting Luo, Harvey Herschman, Hua-Jung Li. EP4 Antagonist-Elicited Extracellular Vesicles from Mesenchymal Stem Cells Rescue Cognition/Learning Deficiencies by Restoring Brain Cellular Functions. STEM CELLS Transl Med. 2019;8:707–723.
6. Takov, K., He, Z., Johnston, H.E. et al. Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential. Basic Res Cardiol 2020;115,26.
7. Y. Zhu, J. Li, Z. Pang, Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development, Asian journal of pharmaceutical sciences (2020).
8. Vanessa Castelli, Ivana Antonucci, Michele d’Angelo, Alessandra Tessitore, Veronica Zelli, Elisabetta Benedetti, Claudio Ferri, Giovambattista Desideri, Cesar Borlongan, Liborio Stuppia, Annamaria Cimini. Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model. STEM CELLS Transl Med. 2021;10:251–266.
9. Goncalves, S.; Gaivao, I., Natural Ingredients Common in the Tras-os-Montes Region (Portugal) for Use in the Cosmetic Industry: A Review about Chemical Composition and Antigenotoxic Properties. Molecules 2021, 26 (17), 5255-5277.
10. Mohd-Setapar, S. H.; John, C. P.; Mohd-Nasir, H.; Azim, M. M.; Ahmad, A.; Alshammari, M. B., Application of Nanotechnology Incorporated with Natural Ingredients in Natural Cosmetics. Cosmetics 2022, 9 (6), 110.
11. Guan, Y. L.; Yang, Y. J.; Nagarajan, P.; Ge, Y. J., Transcriptional and signalling regulation of skin epithelial stem cells in homeostasis, wounds and cancer. Exp. Dermatol. 2021, 30 (4), 529-545. https://doi.org/10.1007/s00395-020-0785-3
12. Chansaenroj A., Yodmuang S., and Ferreira J. N., Trends in aalivary gland tissue engineering: from stem cells to secretome and organoid bioprinting, Tissue Engineering Part B: Reviews. (2021) 27,no.2, 155–165 https://doi.org/10.1089/ten.teb.2020.0149.
13. Liu, Y; Chen, X; R. Shen; X. Wang; X.S. Zheng; K. Zhao; Q.J. Chen; F. Deng; L.L. Liu, B. Yan, F.X. Zhan, Y.Y. Wang, G.F. Xiao, Z.L. Shi, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature 579(7798) (2020) 270-273.
14. Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).
15. Ma S., Jiang Y., Qian Y., Du J., Yu X., Luo S., and Chen Z., The emerging biological functions of exosomes from dental tissue-derived mesenchymal stem cells, Cellular Reprogramming. (2023) 25, no. 2,53–64.
16. Lan Y., Liu F., Chang L., Liu L., Zhang Y., Yi M., Cai Y., Feng J., Han Z., Han Z., and Zhu X., Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia, BMC Pediatrics. (2021) 21, no. 1.
17. You X., Yang Q., Yan K., Wang S.-R., Huang R.-R., Wang S.-Q., Gao C.-Y., Li L., and Lian Z.-X., Multi-omics profiling identifies pathways associated with CD8+ T-cell activation in severe aplastic anemia, Frontiers in Genetics. (2022) 12.
18. Wang Y., Keshavarz M., Barhouse P., and Smith Q., Strategies for regenerative vascular tissue engineering, Advanced Biology. (2023) 7, no. 5, 2200050.